You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interleukin-1 receptor antagonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Netosis During COVID-19, Under Treatment With

Active, not recruiting
  • Covid19
    • Paris, France
    • +1 more
    Mar 30, 2022

    Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)

    Completed
    • Intracerebral Haemorrhage
    • IL-1Ra Kineret®
    • IL-1Ra Placebo
    • Manchester, North West, United Kingdom
      Salford Royal NHS Foundation Trust
    Oct 4, 2021

    Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

    Not yet recruiting
    • Pericarditis
    • IL1RA Antibody Assay
    • suPAR Testing
    • Homburg, Germany
    • +8 more
    Jun 22, 2023

    Coronavirus Disease(COVID)-19 Acute Respiratory Distress

    Recruiting
    • COVID
    • Acute Respiratory Distress Syndrome
    • Angiotensin II
    • Interleukin-1 receptor antagonist
    • London, United Kingdom
      Guy's & St Thomas' Hospital
    Aug 3, 2021

    Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)

    Recruiting
    • Subarachnoid Hemorrhage
    • Plymouth, Devon, United Kingdom
    • +11 more
    May 16, 2022

    Polycystic Ovary Syndrome Trial in Basel (IL-1 receptor antagonist Anakinra)

    Completed
    • Polycystic Ovary Syndrome
    • IL-1 receptor antagonist Anakinra
    • Basel, Switzerland
      University Hospital Basel Endocrinology, Diabetes and Metabolism
    Jan 26, 2021

    Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

    Recruiting
    • Rectal Cancer
    • Kineret 100 MG in 0.67 ML Prefilled Syringe
    • +3 more
    • Frankfurt, Germany
      University Hospital Goethe University Frankfurt
    Aug 23, 2022

    Heart Failure Trial in Salt Lake City (Anakinra)

    Completed
    Has Results
    • Heart Failure
    • Salt Lake City, Utah
      University of Utah
    Feb 3, 2020

    Lowering InterLeukin-1 Receptor Antagonist Concentrations After

    Unknown status
    • Tuberculosis
      • Phon Phen, Cambodia
      • +1 more
      Feb 5, 2020

      GDM Patients and Serum Amyloid A and Interleukin-1 Receptor

      Completed
      • Gestational Diabetes
      • Serum amyloid A values
      • Interleukin-1 (IL-1) receptor antagonist values (A-SAA and IL-1Ra)
      • Istanbul, Turkey
        Kanuni Sultan Süleyman Training and Research Hospital
      May 21, 2020

      COVID-19 Pnemonia Trial in Spain (Anakinra 149 MG/ML Prefilled Syringe [Kineret])

      Completed
      • COVID-19 Pnemonia
      • Anakinra 149 MG/ML Prefilled Syringe [Kineret]
      • Zaragoza, Aragón, Spain
      • +11 more
      May 27, 2021

      Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

      Completed
      Has Results
      • Epidermolysis Bullosa
      • Serlopitant Tablet
      • Placebo Oral Tablet
      • Redwood City, California
        Stanford University
      Nov 30, 2022

      Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

      Recruiting
      • Safety Issues
      • +2 more
      • Washington, District of Columbia
        Georgetown University
      Dec 1, 2022

      Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

      Active, not recruiting
      • Prostatic Neoplasms
      • Beijing, China
      • +3 more
      Jan 17, 2023

      Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)

      Not yet recruiting
      • Depressive Disorder, Major
      • Anxiety Disorder
      • Nociceptin Receptor Antagonist
      • Aversive stimuli
      • (no location specified)
      Nov 3, 2022

      End-Stage Renal Disease Trial in United States (Anakinra, Placebo)

      Completed
      • End-Stage Renal Disease
      • Washington, District of Columbia
      • +3 more
      Jan 19, 2022

      Diabetes Type 2 in Obese, Inflammation, Metabolic Disease Trial in Basel (Anakinra Prefilled Syringe)

      Recruiting
      • Diabetes Mellitus Type 2 in Obese
      • +3 more
      • Anakinra Prefilled Syringe
      • Basel, Basel BS, Switzerland
        University Hospital Basel
      Sep 7, 2021

      B Cell ALL, B-Cell Lymphoma, B-cell Non Hodgkin Lymphoma Trial in Hackensack, New York (Anakinra)

      Recruiting
      • B Cell ALL
      • +2 more
      • Hackensack, New Jersey
      • +1 more
      Aug 22, 2022

      Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

      Active, not recruiting
      • Exercise
      • Histamine
      • Placebo: Placebo + exercise training.
      • +2 more
      • Ghent, Oost-Vlaanderen, Belgium
        Department of movement and sports sciences, Ghent University, Be
      Nov 8, 2022

      Vitamin D Receptor, Interleukin-1A and Interleukin-1B Gene

      Completed
      • Periodontitis
      • Polymorphism, Restriction Fragment Length
        • İstanbul, Maltepe, Turkey
        • +1 more
        Nov 30, 2021

        Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

        Not yet recruiting
        • Renal Cell Carcinoma
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 11, 2022

        Interleukin-4 Receptor, Monoclonal Antibody Trial (Interleukin-4 receptor responders 1, Interleukin-4 receptor responders 2,

        Not yet recruiting
        • Interleukin-4 Receptor
        • Monoclonal Antibody
        • Interleukin-4 receptor responders 1
        • +2 more
        • (no location specified)
        Jul 20, 2022

        Advanced Solid Tumor, Breast Cancer, Non Small Cell Lung Cancer Trial (MB1707)

        Not yet recruiting
        • Advanced Solid Tumor
        • +4 more
        • (no location specified)
        Jul 18, 2022

        Pre-frail Elderly Trial in Jakarta (Cholecalciferol, Placebo)

        Completed
        • Pre-frail Elderly
        • Jakarta, DKI Jakarta, Indonesia
          Cipto Mangunkusumo General Hospital
        Jan 25, 2023

        Spinal Cord Injuries Trial in Toledo (Rimonabant)

        Not yet recruiting
        • Spinal Cord Injuries
        • Toledo, Spain
          Hospital Nacional de Paraplejicos
        Nov 14, 2022